Novavax claims its experimental COVID-19 vaccine produced high levels of antibodies

American vaccine development company vavax said on August 4 that its experimental COVID-19 vaccine produced high levels of antibodies against vel coronavirus, according to initial data that came from a small and early-st clinical trial. It also said that it will start an important phase third trial as soon as in September, company also ded that it is able to produce 1 billion to 2 billion doses of vaccine incoming 2021. Talking to international media vavax research chief Gregory Glenn told that late-st clinical trial could potentially bring eugh data to obtain regulatory approvals as early as December.

Re: 'India Must Crack Covid Vaccine For World; 6 Indian Companies In Race': Niti Aayog CEO

According to Maryland-based vavax its vaccine candidate NVX-CoV2373 produced higher levels of antibodies in healthy volunteers after two doses as compare to recovered COVID-19 patients. This breakthrough is seen as ray of hope by company. vavax vaccine is one of handful programs which got US funding under Operation Warp Speed, program started by Whitehouse to accelerate access to vaccines and treatments to curb vel coronavirus.

Re: Debate Begins For Who's First In Line For COVID-19 Vaccine

vavax’s vaccine contains synsized pieces of surface protein that coronavirus uses to inve human cells and it increases production of antibodies to fight infection. In time of corona havoc, people are looking at vaccine to end coronavirus which has claimed more than 695,000 lives worldwide.

Re: Coronavirus Vaccine Study Begins In New Orleans

United States government extends support

In month of July, United States government agreed to pay vavax $1.6 billion to help cover costs related to testing and manufacturing vaccine, with aim of procuring 100 million doses by coming January 2021. trial was started in late May and vaccine was tested on 106 subjects d 18 to 59, phase one looked at vaccine’s safety and ability to induce immune responses. company tested 5 micrograms and 25 microgram doses of vaccine, with and without juvant. In future company would likely move forward with lower dose.

(Im Credit-AP)

Re: US Grants $1.6 Billion To vavax For COVID-19 Vaccine Project Under Operation Warp Speed